Great points. I think Nadar mis spoke about the
Post# of 148184
I think we need to make a reasonable profit so we can push more indications forward.
Lastly, I think we are going to get compassionate use in US, followed quickly by UK. This will save many lives, but I am concerned it will slow down enrollment in the trials.
Perhaps the FDA has another plan in mind.